Flow Capital Announces Additional $2.3 Million Tranche of
TORONTO, March 22, 2024 (GLOBE NEWSWIRE) -- Flow Capital Corp. (TSXV:FW) (“Flow Capital” and “Company”), a leading provider of flexible growth capital...
Stay updated with breaking news from Looking Information. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TORONTO, March 22, 2024 (GLOBE NEWSWIRE) -- Flow Capital Corp. (TSXV:FW) (“Flow Capital” and “Company”), a leading provider of flexible growth capital...
Saturn Oil & Gas Inc. is pleased to report its financial and operating results for the three and twelve months ended December 31, 2023.2023 was a tremendous year of progress for Saturn in creating...
PREVENAR 20® offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of...
NEW YORK--(BUSINESS WIRE)--Mar 13, 2024--
NEW YORK, March 13, 2024--Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for the company’s 20-valent pneumococcal conjugate vaccine, marketed in the European Union under the brand name PREVENAR 20®, for active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age.